Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
$2.67+0.12 (+4.71%)
Close on Nov 17, 2026Market cap $92.82MP/E –Yield –
Anixa Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Anixa Biosciences's price to sales ratio was 245.1× on Aug 31, 2022, against 243.2× a year earlier. Over the last 5 years it ranged from 2.1× to 288.7×, with a median of 86.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Aug 31, 2022 | 245.1× | +70.8 |
| 2021 | Dec 31, 2021 | 174.3× | −15.8 |
| 2020 | May 29, 2020 | 190.1× | −76.7 |
| 2019 | Dec 31, 2019 | 266.8× | +199.8 |
| 2018 | Dec 31, 2018 | 67.0× | −41.1 |
| 2017 | Dec 29, 2017 | 108.1× | −49.4 |
| 2016 | Dec 30, 2016 | 157.5× | +154.7 |
| 2015 | Dec 31, 2015 | 2.8× | −3.8 |
| 2014 | Dec 31, 2014 | 6.6× | −95.7 |
| 2013 | Dec 31, 2013 | 102.3× | +66.8 |
| 2012 | Dec 31, 2012 | 35.4× | +16.1 |
| 2011 | Dec 30, 2011 | 19.3× | −24.9 |
| 2010 | Dec 31, 2010 | 44.2× | – |
See a number that looks wrong?